Cargando…

Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone

Base excision repair (BER) is an essential pathway for pancreatic ductal adenocarcinoma (PDA) survival. Attempts to target this repair pathway have failed due to lack of tumor-selectivity and very limited efficacy. The NAD(P)H:Quinone Oxidoreductase 1 (NQO1) bioactivatable drug, ß-lapachone (ARQ761...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakrabarti, Gaurab, Silvers, Molly A., Ilcheva, Mariya, Liu, Yuliang, Moore, Zachary R., Luo, Xiuquan, Gao, Jinming, Anderson, Glenda, Liu, Lili, Sarode, Venetia, Gerber, David E., Burma, Sandeep, DeBerardinis, Ralph J., Gerson, Stanton L., Boothman, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658501/ https://www.ncbi.nlm.nih.gov/pubmed/26602448 http://dx.doi.org/10.1038/srep17066

Ejemplares similares

Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone
por: Chakrabarti, Gaurab, et al.
Publicado: (2015)

Targeting Base Excision Repair in Cancer: NQO1-Bioactivatable Drugs Improve Tumor Selectivity and Reduce Treatment Toxicity Through Radiosensitization of Human Cancer
por: Starcher, Colton L., et al.
Publicado: (2020)

Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis
por: Gerber, David E., et al.
Publicado: (2018)

NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone
por: Moore, Z, et al.
Publicado: (2015)

Membrane‐Permeant, Bioactivatable Coumarin Derivatives for In‐Cell Labelling
por: Schultz, Madeleine, et al.
Publicado: (2022)

NQO1 is Required for β-Lapachone-Mediated Downregulation of Breast-Cancer Stem-Cell Activity
por: Kim, Dong Wook, et al.
Publicado: (2018)

β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers
por: Yang, Yang, et al.
Publicado: (2017)

β-lapachone ameliorates murine cisplatin nephrotoxicty – NAD+, NQO1, and SIRT1 at the crossroads of metabolism, injury, and inflammation
por: Lu, Christopher Y.
Publicado: (2014)

β-Lapachone Induces Acute Oxidative Stress in Rat Primary Astrocyte Cultures that is Terminated by the NQO1-Inhibitor Dicoumarol
por: Steinmeier, Johann, et al.
Publicado: (2020)

Synergistic Effect of β-Lapachone and Aminooxyacetic Acid on Central Metabolism in Breast Cancer
por: Chang, Mario C., et al.
Publicado: (2022)

Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways
por: Chakrabarti, Gaurab, et al.
Publicado: (2015)

Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone
por: Torrente, Laura, et al.
Publicado: (2020)

β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation
por: Zhao, Wenxiu, et al.
Publicado: (2021)

Arylamino-nor-β-lapachone derivative-induced apoptosis in human prostate cancer cells: involvement of NAD(P)H:quinone oxidoreductase (NQO1)
por: Cavalcanti, Bruno C, et al.
Publicado: (2013)

MTHFD2 Blockade Enhances the Efficacy of β-Lapachone Chemotherapy With Ionizing Radiation in Head and Neck Squamous Cell Cancer
por: Shukla, Kirtikar, et al.
Publicado: (2020)

NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance
por: Li, Xiaoguang, et al.
Publicado: (2019)

Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues
por: Ferraz da Costa, Danielly C., et al.
Publicado: (2020)

The cancer cell ‘energy grid’: TGF-β1 signaling coordinates metabolism for migration
por: Jiang, Lei, et al.
Publicado: (2015)

Redox modulation of NQO1
por: Siegel, David, et al.
Publicado: (2018)

The possibility of low isomerization of β-lapachone in the human body
por: Lee, Kyung Min, et al.
Publicado: (2021)

Enhancement of radiation effect using beta-lapachone and underlying mechanism
por: Ahn, Ki Jung, et al.
Publicado: (2013)

Antibacterial and Antibiofilm Activities of β-Lapachone by Modulating the Catalase Enzyme
por: Mir, Mushtaq Ahmad, et al.
Publicado: (2023)

In vitro effects of lapachol and β-lapachone against Leishmania amazonensis
por: Ramos-Milaré, Á.C.F.H., et al.
Publicado: (2023)

Phosphorylation of EXO1 by CDKs 1 and 2 regulates DNA end resection and repair pathway choice
por: Tomimatsu, Nozomi, et al.
Publicado: (2014)

Machine intelligence decrypts β-lapachone as an allosteric 5-lipoxygenase inhibitor
por: Rodrigues, Tiago, et al.
Publicado: (2018)

Characterization and trypanocidal activity of a β-lapachone-containing drug carrier
por: Barbosa, Juliana M. C., et al.
Publicado: (2021)

Metabolic heterogeneity in cancer
por: DeBerardinis, Ralph J
Publicado: (2014)

Q&A: Targeting metabolism to diagnose and treat cancer
por: DeBerardinis, Ralph J
Publicado: (2014)

Superparamagnetic Iron Oxide Nanoparticles: Amplifying ROS Stress to Improve Anticancer Drug Efficacy
por: Huang, Gang, et al.
Publicado: (2013)

Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1
por: Salido, Eduardo, et al.
Publicado: (2022)

The diverse functionality of NQO1 and its roles in redox control
por: Ross, David, et al.
Publicado: (2021)

Temperature-Sensitive Gels for Intratumoral Delivery of β-Lapachone: Effect of Cyclodextrins and Ethanol
por: Cunha-Filho, Marcilio S. S., et al.
Publicado: (2012)

Impact of Micellar Vehicles on in situ Intestinal Absorption Properties of Beta-Lapachone in Rats
por: Jang, Soung Baek, et al.
Publicado: (2013)

β-Lapachone suppresses the lung metastasis of melanoma via the MAPK signaling pathway
por: Kee, Ji-Ye, et al.
Publicado: (2017)

β-Lapachone Increases Survival of Septic Mice by Regulating Inflammatory and Oxidative Response
por: de B. Oliveira, Ana L., et al.
Publicado: (2020)

A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity.
por: Ross, D., et al.
Publicado: (1996)

Pyruvate dehydrogenase activity is required for optimal growth under lipid deficient conditions
por: Rajagopalan, Kartik, et al.
Publicado: (2014)

Implications of NQO1 in cancer therapy
por: Oh, Eun-Taex, et al.
Publicado: (2015)

The Role of NQO1 in Ovarian Cancer
por: Tossetta, Giovanni, et al.
Publicado: (2023)

β-Lapachone Ameliorates Lipotoxic Cardiomyopathy in Acyl CoA Synthase Transgenic Mice
por: Jeong, Moon Hee, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jcujc05ir0ef54eml2qcupvpk5